share_log

CG Oncology | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Xiangmin Cui(8.2%),Decheng Capital Global Life Sciences Fund IV, L.P.(7.4%), etc.

SEC announcement ·  Apr 9 19:16
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more